Latest Articles

Ke Wenzhe’s USB controversy: People’s Party demands thorough investigation amidst media scrutiny

The USB drive, which reportedly includes detailed financial documentation, has become a focal point in ongoing political discussions. The contents of the drive have raised questions about potential financial irregularities and conflicts of interest, prompting calls for clarity from both the public and political spheres. The People's Party, to which Ko Wenzhe is affiliated, has emphasized the need for an impartial examination of the evidence rather than allowing media coverage to shape public opinion.

blank

Ke Wenzhe faces backlash over Jinghua City floor area ratio claims amidst legal scrutiny

Councilors from both major political camps have openly criticized Ko. Democratic Progressive Party (DPP) Councilor He Menghua has labeled Ko’s statements as outright lies, highlighting that the issue of Jinghua City's floor area ratio had been raised by city councilors as early as November 2021. He Menghua pointed out that Ko Wenzhe was questioned on related matters at least three years prior, making his recent claims implausible. DPP Councilor Hsu Shu-hua had also brought up similar concerns regarding floor area bonuses in 2023, further questioning Ko’s credibility.

blank

Former Taoyuan City Mayor Zheng Wencan sentenced to 12 years in prison amid corruption scandal

Despite the gravity of the charges and the detailed indictment, Zheng Wencan continues to deny the accusations. His refusal to acknowledge his wrongdoing has been met with frustration by various political figures, including Kuomintang legislator Niu Xuting. Niu criticized Zheng's persistent denial, describing it as “hard to accept” given the comprehensive nature of the evidence presented. He emphasized that Zheng's case not only tarnishes the integrity of the Democratic Progressive Party (DPP) but also has serious repercussions for urban development projects in Taoyuan.

blank

Baorui Pharmaceuticals to become top shareholder in Taifu Biotech, marking a new era in Taiwan’s biotech sector

The acquisition involves Taifu Biotech issuing new shares to Baorui, which will exchange its shares in Baorui Biotech, focusing on large-molecule CDMO (Contract Development and Manufacturing Organization) technology, for an equivalent number of Taifu shares. This merger will significantly enhance Baorui's footprint in the biotech sector and solidify its standing as a leading player in the industry.

blank

Ke Wenzhe under scrutiny for handling of election subsidies

Ke Wenzhe has acknowledged the purchase, stating that his actions align with what he described as common practice among other political parties. According to Ke, the convention is for two-thirds of the election subsidies to be allocated to the individual candidate, with one-third going to the party's central committee. For the recent presidential election, Ke's campaign received a total of 110,713,980 yuan in subsidies. Based on the conventional split, this would imply that approximately 73,809,320 yuan should be attributed to personal use.

Showing 80 of 257 articles